148 related articles for article (PubMed ID: 29518247)
1. Evaluation of PAI-1 in endometriosis using a homologous immunocompetent mouse model.
Buigues A; Ferrero H; Martínez J; Pellicer N; Pellicer A; Gómez R
Biol Reprod; 2018 Aug; 99(2):326-335. PubMed ID: 29518247
[TBL] [Abstract][Full Text] [Related]
2. A novel homologous model for noninvasive monitoring of endometriosis progression.
Ferrero H; Buigues A; Martínez J; Simón C; Pellicer A; Gómez R
Biol Reprod; 2017 Feb; 96(2):302-312. PubMed ID: 28203742
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol is a potent inhibitor of vascularization and cell proliferation in experimental endometriosis.
Rudzitis-Auth J; Menger MD; Laschke MW
Hum Reprod; 2013 May; 28(5):1339-47. PubMed ID: 23427233
[TBL] [Abstract][Full Text] [Related]
4. In situ localization of mRNA for the fibrinolytic factors uPA, PAI-1 and uPAR in endometriotic and endometrial tissue.
Bruse C; Radu D; Bergqvist A
Mol Hum Reprod; 2004 Mar; 10(3):159-66. PubMed ID: 14981142
[TBL] [Abstract][Full Text] [Related]
5. Pregnancy affects morphology of induced endometriotic lesions in a mouse model through alteration of proliferation and angiogenesis.
Cohen J; Naoura I; Castela M; Von N'Guyen T; Oster M; Fontaine R; Chabbert-Buffet N; Darai E; Aractingi S
Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():70-7. PubMed ID: 25461356
[TBL] [Abstract][Full Text] [Related]
6. The effects of ergot and non-ergot-derived dopamine agonists in an experimental mouse model of endometriosis.
Delgado-Rosas F; Gómez R; Ferrero H; Gaytan F; Garcia-Velasco J; Simón C; Pellicer A
Reproduction; 2011 Nov; 142(5):745-55. PubMed ID: 21862695
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA expression profile in endometriosis: its relation to angiogenesis and fibrinolytic factors.
Braza-Boïls A; Marí-Alexandre J; Gilabert J; Sánchez-Izquierdo D; España F; Estellés A; Gilabert-Estellés J
Hum Reprod; 2014 May; 29(5):978-88. PubMed ID: 24608518
[TBL] [Abstract][Full Text] [Related]
8. Co-operation between the AKT and ERK signaling pathways may support growth of deep endometriosis in a fibrotic microenvironment in vitro.
Matsuzaki S; Darcha C
Hum Reprod; 2015 Jul; 30(7):1606-16. PubMed ID: 25976656
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of KIF20A by BKS0349 reduces endometriotic lesions in a xenograft mouse model.
Ferrero H; Corachán A; Quiñonero A; Bougeret C; Pouletty P; Pellicer A; Domínguez F
Mol Hum Reprod; 2019 Sep; 25(9):562-571. PubMed ID: 31365745
[TBL] [Abstract][Full Text] [Related]
10. Differences in growth and vascularization of ectopic menstrual and non-menstrual endometrial tissue in mouse models of endometriosis.
Nenicu A; Yordanova K; Gu Y; Menger MD; Laschke MW
Hum Reprod; 2021 Jul; 36(8):2202-2214. PubMed ID: 34109385
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the potential therapeutic effects of a double-stranded RNA mimic complexed with polycations in an experimental mouse model of endometriosis.
García-Pascual CM; Martínez J; Calvo P; Ferrero H; Villanueva A; Pozuelo-Rubio M; Soengas M; Tormo D; Simón C; Pellicer A; Gómez R
Fertil Steril; 2015 Nov; 104(5):1310-8. PubMed ID: 26297642
[TBL] [Abstract][Full Text] [Related]
12. Thrombospondin-1 mimetic peptide ABT-898 affects neovascularization and survival of human endometriotic lesions in a mouse model.
Nakamura DS; Edwards AK; Virani S; Thomas R; Tayade C
Am J Pathol; 2012 Aug; 181(2):570-82. PubMed ID: 22727957
[TBL] [Abstract][Full Text] [Related]
13. A peptide inhibitor of synuclein-γ reduces neovascularization of human endometriotic lesions.
Edwards AK; Ramesh S; Singh V; Tayade C
Mol Hum Reprod; 2014 Oct; 20(10):1002-8. PubMed ID: 25024138
[TBL] [Abstract][Full Text] [Related]
14. Impact of epidermal growth factor and transforming growth factor beta-1 on the release of fibrinolytic factors from cultured endometrial and ovarian endometriotic stromal cells.
Guan YM; Carlberg M; Bruse C; Bergqvist A
Gynecol Obstet Invest; 2003; 55(1):7-13. PubMed ID: 12624545
[TBL] [Abstract][Full Text] [Related]
15. Blocking of stromal cell-derived factor-1 reduces neoangiogenesis in human endometriosis lesions in a mouse model.
Virani S; Edwards AK; Thomas R; Childs T; Tayade C
Am J Reprod Immunol; 2013 Nov; 70(5):386-97. PubMed ID: 23650939
[TBL] [Abstract][Full Text] [Related]
16. Notch signaling controls sprouting angiogenesis of endometriotic lesions.
Körbel C; Gerstner MD; Menger MD; Laschke MW
Angiogenesis; 2018 Feb; 21(1):37-46. PubMed ID: 28993956
[TBL] [Abstract][Full Text] [Related]
17. Vascular disrupting effects of combretastatin A4 phosphate on murine endometriotic lesions.
Feng D; Menger MD; Laschke MW
Fertil Steril; 2013 Nov; 100(5):1459-67. PubMed ID: 23993929
[TBL] [Abstract][Full Text] [Related]
18. ENMD-1068, a protease-activated receptor 2 antagonist, inhibits the development of endometriosis in a mouse model.
Wang Y; Lin M; Weng H; Wang X; Yang L; Liu F
Am J Obstet Gynecol; 2014 Jun; 210(6):531.e1-8. PubMed ID: 24495669
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase inhibitors can control the progression of endometriosis in vitro and in vivo.
Ngô C; Nicco C; Leconte M; Chéreau C; Arkwright S; Vacher-Lavenu MC; Weill B; Chapron C; Batteux F
J Pathol; 2010 Oct; 222(2):148-57. PubMed ID: 20821752
[TBL] [Abstract][Full Text] [Related]
20. Basal release of urokinase plasminogen activator, plasminogen activator inhibitor-1, and soluble plasminogen activator receptor from separated and cultured endometriotic and endometrial stromal and epithelial cells.
Bruse C; Guan Y; Carlberg M; Carlström K; Bergqvist A
Fertil Steril; 2005 Apr; 83 Suppl 1():1155-60. PubMed ID: 15831288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]